Missense mutations in the human SDHB gene increase protein degradation without altering intrinsic enzymatic function
Open Access
- 26 July 2012
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 26 (11) , 4506-4516
Abstract
Mutations of succinate dehydrogenase subunit B (SDHB) play a crucial role in the pathogenesis of the most aggressive and metastatic pheochromocytomas (PHEOs) and paragangliomas (PGLs). Although a variety of missense mutations in the coding sequence of the SDHB gene have been found in PHEOs and PGLs, it has been unclear whether these mutations impair mRNA expression, protein stability, subcellular localization, or intrinsic protein function. RT‐PCR and Western blot analysis of SDHB mRNA and protein expression from SDHB‐related PHEOs and PGLs demonstrated intact mRNA expression but significantly reduced protein expression compared to non‐SDHB PHEOs and PGLs. A pulse‐chase assay of common SDHB missense mutations in transfected HeLa cell lines demonstrated that the loss of SDHB function was due to a reduction in mutant protein half‐life, whereas colocalization of SDHB with mitochondria and immunoprecipitation with SDHA demonstrated intact subcellular localization and complex formation. The half‐life of the SDHB protein increased after treatment with histone deacetylase inhibitors (HDACis), implicating the protein quality control machinery in the degradation of mutant SDHB protein. These findings provide the first direct mechanism of functional loss resulting from SDHB mutations and suggest that reducing protein degradation with HDACis may serve as a novel therapeutic paradigm for preventing the development of SDHB‐related tumors.—Yang, C., Matro, J. C., Huntoon, K. M., Ye, D. Y., Huynh, T. T., Fliedner, S. M. J., Breza, J., Zhuang, Z., Pacak, K. Missense mutations in the human SDHB gene increase protein degradation without altering intrinsic enzymatic function. FASEB J. 26, 4506–4516 (2012). www.fasebj.orgKeywords
Funding Information
- National Institute of Child Health and Human Development
- National Institute of Neurological Disorders and Stroke
- National Institutes of Health
This publication has 57 references indexed in Scilit:
- A continuum model for tumour suppressionNature, 2011
- Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic functionProceedings of the National Academy of Sciences, 2011
- Decreased glucocerebrosidase activity in Gaucher disease parallels quantitative enzyme loss due to abnormal interaction with TCP1 and c-CblProceedings of the National Academy of Sciences of the United States of America, 2010
- Recent advances in the genetics of SDH-related paraganglioma and pheochromocytomaFamilial Cancer, 2010
- Inter‐connection between mitochondria and HIFsJournal of Cellular and Molecular Medicine, 2010
- Loss of the SdhB, but Not the SdhA, Subunit of Complex II Triggers Reactive Oxygen Species-Dependent Hypoxia-Inducible Factor Activation and TumorigenesisMolecular and Cellular Biology, 2008
- HIF-Dependent Antitumorigenic Effect of Antioxidants In VivoCancer Cell, 2007
- The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteinsJournal of Clinical Investigation, 2007
- Molecular Chaperones and Protein Quality ControlCell, 2006
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971